Showing 1,658 news articles about Hepatitis & HIV

Filters Content type: Editors' picks Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

New & experimental hepatitis C treatment

$1000 Pill For Hepatitis C Spurs Debate Over Drug Prices

Editor's pick
NPR (blog)
6 January 2014
Hepatitis C treatment

Gilead Sciences, Inc. (GILD): Gilead Seeks To Expand Its Blockbuster Hepatitis Platforms In 2014

Editor's pick
Seeking Alpha
3 January 2014
Hepatitis C transmission & prevention

Patient catches hepatitis C in Edinburgh hospital

Editor's pick
The Scotsman
30 December 2013
New & experimental hepatitis C treatment

Stellar hepatitis C data puts Gilead farther ahead of pack

Editor's pick
Reuters
24 December 2013
Access to healthcare

Life-saving hepatitis C drug approved, but cost is high

Editor's pick
IRIN Plus News
24 December 2013
Access to healthcare

Egyptians hold their breath as new Hepatitis C drugs promise cure

Editor's pick
Ahram Online
24 December 2013
Hepatitis C transmission & prevention

AASLD 2013: HCV levels in semen may correspond to blood viral load

Editor's pick
HIVandHepatitis.com
20 December 2013
Discrimination & the law

US: Activists rally for equal access to transplants for patients with HIV

Editor's pick
Al Jazeera America
20 December 2013
New & experimental hepatitis C treatment

Gilead to seek okay for combo hepatitis C pill in first quarter

Editor's pick
Reuters
18 December 2013
New & experimental hepatitis C treatment

Gilead Announces SVR12 Rates From Three Phase 3 Studies Evaluating a Once-Daily Fixed-Dose Combination of Sofosbuvir and Ledipasvir for Genotype 1 Hepatitis C Patients

Editor's pick
Gilead press release
18 December 2013
Access to healthcare

How patent rules could keep new hepatitis C drug from saving 'millions of lives'

Editor's pick
Global Post
18 December 2013
New & experimental hepatitis C treatment

An interview with Professor Jean-Michel Pawlotsky on how the treatment of HCV infection will change in the near future

Editor's pick
Hepatitis B & C Public Policy Association
17 December 2013
New & experimental hepatitis C treatment

Analysis: Fight for cheap drugs shifts from AIDS to new hepatitis pills

Editor's pick
Reuters
16 December 2013
New & experimental hepatitis C treatment

Why Talk Of A Hepatitis C Price War Should Act As A Warning To The Pharma Industry-At-Large

Editor's pick
Forbes
11 December 2013
New & experimental hepatitis C treatment

Express Scripts Pushes Price Competition for Gilead Drug

Editor's pick
Bloomberg
11 December 2013
New & experimental hepatitis C treatment

AbbVie Demonstrates 96 percent SVR(12) in its Phase III Study of Treatment-Experienced Patients with Genotype 1 Hepatitis C

Editor's pick
AbbVie press release
10 December 2013
Pharmaceutical industry

Activists Condemn Gilead for Exorbitant Price of Their New Hepatitis C Drug

Editor's pick
Fair Pricing Coalition / The Body
10 December 2013
New & experimental hepatitis C treatment

Beyond the Hype: What Sofosbuvir Means—and Doesn’t—for Global Hepatitis C Treatment

Editor's pick
Open Society Foundation
10 December 2013
Hepatitis C treatment

EASL publishes revised clinical practice guidelines to optimise the management of hepatitis C virus

Editor's pick
Eurekalert Inf Dis
9 December 2013
New & experimental hepatitis C treatment

US FDA approves Gilead's $1000-a-day hepatitis C pill

Editor's pick
Reuters
8 December 2013
New & experimental hepatitis C treatment

FDA approves Sovaldi for chronic hepatitis C

Editor's pick
US FDA
8 December 2013
Hepatitis C transmission & prevention

Injection Drug Users Who Know They Have Hepatitis C Practice "Sero-Sharing"

Editor's pick
HIVandhepatitis.com
6 December 2013
New & experimental hepatitis C treatment

Sofosbuvir for Hepatitis C: Simpler, Shorter, Safer?

Editor's pick
Medscape (requires registration)
4 December 2013
Hepatitis B

China's Struggle With Hepatitis B Discrimination

Editor's pick
The Atlantic
4 December 2013